New Research Centers Target How Market Forces Affect Health Care
ROCKVILLE, Md-Three new research centers will focus on how market forces affect the quality of health care, access to it, and its cost. The Agency for Healthcare Research and Quality (AHRQ) expects to support the centers with grants totaling $12.5 million over the next 5 years. The three centers are located at Harvard Medical School, University of California, San Francisco, and RAND, Santa Monica, California.
ROCKVILLE, MdThree new research centers will focus on how market forces affect the quality of health care, access to it, and its cost. The Agency for Healthcare Research and Quality (AHRQ) expects to support the centers with grants totaling $12.5 million over the next 5 years. The three centers are located at Harvard Medical School, University of California, San Francisco, and RAND, Santa Monica, California.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
